m. balíková: toxicological examination 1 toxicology iii. toxicological examination m. balíková
TRANSCRIPT
M. Balíková: Toxicological examination
1
TOXICOLOGYTOXICOLOGY
III. Toxicological examinationIII. Toxicological examination
M. BalíkováM. Balíková
M. Balíková: Toxicological examination
2
Why to care about Why to care about toxicological toxicological examinationexamination
Understanding drug effectsUnderstanding drug effectsDifferential diagnosisDifferential diagnosisCorrect and effective therapy, Correct and effective therapy,
reduction of adverse drug reduction of adverse drug effectseffects
Appropriate subsequent Appropriate subsequent measures – social or forensicmeasures – social or forensic
M. Balíková: Toxicological examination
3
Information in a request Information in a request for toxicological for toxicological
examinationexamination• Name of a person requiring Name of a person requiring
examination, date of sampling, date of examination, date of sampling, date of autopsyautopsy
• Circumstances of an incident, Circumstances of an incident, estimated time of drug estimated time of drug application/time of deathapplication/time of death
• Medical history of a person, medical Medical history of a person, medical treatmenttreatment
• Note of occupation, hobiesNote of occupation, hobies• Clinical symptoms/Preliminary Clinical symptoms/Preliminary
pathological report, if availablepathological report, if available
M. Balíková: Toxicological examination
4
General sample General sample requirements for requirements for
toxicologytoxicology• Whole bloodWhole blood
a) 10 ml into plain tubea) 10 ml into plain tubeb) 10 ml into 1-2% NaFb) 10 ml into 1-2% NaF
• UrineUrine, 50-100 ml, 50-100 ml (liver, kidney - can substitute urine (liver, kidney - can substitute urine
if not available) if not available)• Gastric content, 50 – 100 mlGastric content, 50 – 100 ml• Scene materialScene material• Other tissues (brain, lung, vitreous Other tissues (brain, lung, vitreous
humour, fat, hair……)humour, fat, hair……)
M. Balíková: Toxicological examination
5
Drug detection windowsDrug detection windowsa) samplea) sampleb) methodb) method
M. Balíková: Toxicological examination
6
Different sample typesDifferent sample typesSpecimeSpecimenn
AdvantageAdvantage DisadvantaDisadvantagege
CommentComment
BloodBlood Present Present parent parent compoundscompounds
QuantitationQuantitation
Limited Limited volumevolume
Trace Trace concentratioconcentrationsns
Careful Careful individual individual interpretatiinterpretationon
UrineUrine Large Large volumevolume
High High concentr.concentr.
Easier/Easier/longer longer detectiondetection
Often not Often not availableavailable
MetabolitesMetabolites
Quantitative Quantitative data not data not usefuluseful
Standard Standard sample for sample for initial initial screeningscreening
Gastric Gastric contentcontent
Useful after Useful after drug drug ingestioningestion
Variable Variable samplesample
AdditionAdditional al tissuestissues
May contain May contain high high concentratioconcentrationsns
Analysis may help to Analysis may help to interpret postmortem interpret postmortem blood data.blood data. Quantitative Quantitative data - problemsdata - problems
M. Balíková: Toxicological examination
7
Hair sample – to get information Hair sample – to get information about the life style of a subject in about the life style of a subject in
the pastthe past• Drugs are located in the hair in Drugs are located in the hair in
relation to the time when appeared in relation to the time when appeared in blood blood
• Different hair growth rate at the bodyDifferent hair growth rate at the body• Cyclus of hair growth, anagen 85% ….Cyclus of hair growth, anagen 85% ….• Ideal sample at the vertex of the headIdeal sample at the vertex of the head• Before cutting close to the skin - tie Before cutting close to the skin - tie
the strand with the cotton threadthe strand with the cotton thread• Correct sampling: Correct sampling:
M. Balíková: Toxicological examination
8
Toxicological laboratory Toxicological laboratory diagnosticsdiagnostics
1)1) Nonspecific preliminary methods for Nonspecific preliminary methods for screeningscreening
2)2) Specific methods ( confirmation, Specific methods ( confirmation, quantificationquantification
For pharmaceuticals, illegal drugs:For pharmaceuticals, illegal drugs:ad1) Immunochemical screening, colour ad1) Immunochemical screening, colour
reactionsreactionsad 2) Chromatographic systems, mass ad 2) Chromatographic systems, mass
spectrometry (MS)spectrometry (MS)
UNKNOWN DRUG – Systematic toxicological analysis – UNKNOWN DRUG – Systematic toxicological analysis – STA STA logical sequence of applied methodslogical sequence of applied methods
M. Balíková: Toxicological examination
9
Immunoassays in Immunoassays in toxicologytoxicology
ADVANTAGESADVANTAGES• Technically Technically
simplesimple• SensitiveSensitive• Rapid Rapid • Important initial Important initial
information information about sampleabout sample
• On site On site performanceperformance
DISADVANTAGESDISADVANTAGES• Not all drugs detectedNot all drugs detected• Group detection onlyGroup detection only• Potentional Potentional
interferencesinterferences• Preliminary resultsPreliminary results• Confirmation Confirmation
necessarynecessary• Continuous reagent Continuous reagent
consumption, supplyconsumption, supply
M. Balíková: Toxicological examination
10
Immunoassays – Principle Immunoassays – Principle - 1- 1
Interaction of the target molecule Interaction of the target molecule ((antigen-drugantigen-drug) with a corresponding) with a corresponding antibodyantibody
To generate measurable signal or visual To generate measurable signal or visual detection:detection:
Antibody for the drug being assayedAntibody for the drug being assayed
Labelled form of the structurally related Labelled form of the structurally related drug drug or labelled antibodyor labelled antibody
Competition between the antigen in a sample and Competition between the antigen in a sample and labelled antigen (reagent) for binding to the fixed labelled antigen (reagent) for binding to the fixed amount of the antibody to create the specific amount of the antibody to create the specific immunocompleximmunocomplex::
M. Balíková: Toxicological examination
11
Immunoassays – Principle Immunoassays – Principle - 2- 2
The proportionThe proportion of labelled drug molecules of labelled drug molecules bound in the complex is inversely proportional bound in the complex is inversely proportional to the number of unlabelled drug molecules in to the number of unlabelled drug molecules in the samplethe sample
VARIOUS SPECIFICITY of ANTIBODIESVARIOUS SPECIFICITY of ANTIBODIES
1) for 1) for SCREENINGSCREENING – detection of selected – detection of selected groups groups (barbiturates)(barbiturates)
2) for 2) for QUANTITATIONQUANTITATION of specific individual of specific individual (phenobarbitone)(phenobarbitone)
M. Balíková: Toxicological examination
12
INITIAL TOXICOLOGICAL INITIAL TOXICOLOGICAL SCREENING by SCREENING by
IMMUNOASSSAYSIMMUNOASSSAYSAdopted cut off valuesAdopted cut off values
Cut off need not be Cut off need not be LOD LOD
Lower cut off – more FPLower cut off – more FP
High cut off – more FNHigh cut off – more FN
Positive detection need to Positive detection need to be confirmed by a specific be confirmed by a specific method (GC-MS)method (GC-MS)
Confirmatory method – Confirmatory method – higher sensitivityhigher sensitivity
M. Balíková: Toxicological examination
13
Immunoscreening Immunoscreening Cut off valuesCut off values
Selection negative / positive Selection negative / positive samples by definitionsamples by definition
1)1) Instrumental methods – flexible, Instrumental methods – flexible, adaptableadaptable
2)2) On site testing – fixed cut off valueOn site testing – fixed cut off value
M. Balíková: Toxicological examination
14
Cut off value and detection Cut off value and detection windowswindows
Example:Example:
THCOOH THCOOH detection detection in urine in urine by three by three various various methods – methods – different different detection detection windowswindows
M. Balíková: Toxicological examination
15
Various sVarious specificity of antibodies pecificity of antibodies Compound cross reactivities Compound cross reactivities
1) 1) Different reactivities of Different reactivities of related drugs in a related drugs in a selected group – selected group – insufficient sensitivity insufficient sensitivity for MDMA detection -for MDMA detection - FNFN
Modification of cut off – Modification of cut off – method adaptation for method adaptation for MDMA detection tooMDMA detection too
2) Adulterants, dilution - FN
3) Reactivities of unwanted substances – FP
M. Balíková: Toxicological examination
16
CONFIRMATIONCONFIRMATION
Basic principle in forensic toxicology :Basic principle in forensic toxicology :
Verification of preliminary results by Verification of preliminary results by another independent method – more another independent method – more specific, more sensitivespecific, more sensitive
Identification of specific compoundsIdentification of specific compounds
Individual compounds differ in Individual compounds differ in potency/toxicity (codeine – morphine)potency/toxicity (codeine – morphine)
Forensic aspects for drug Forensic aspects for drug distinguishing distinguishing
M. Balíková: Toxicological examination
17
Drug detection by Drug detection by chromatographychromatography
ADVANTAGESADVANTAGES Flexible open Flexible open
systemssystems Possibility to expand Possibility to expand
and updateand update Individual drugsIndividual drugs Uncommon drugsUncommon drugs More selectiveMore selective Less consumablesLess consumables
DISADVANTAGESDISADVANTAGES Sample Sample
preparationpreparation Time consumingTime consuming Reference Reference
substances substances neededneeded
Experienced Experienced personalpersonal
M. Balíková: Toxicological examination
18
STA and METHOD COMBINATIONSTA and METHOD COMBINATION
TLCTLC No instrumentNo instrument Flexible open systemFlexible open system Reference standards Reference standards
necessarynecessary Lower separation Lower separation
efficiencyefficiency Lower sensitivity-Lower sensitivity-
high drug high drug concentrationsconcentrations
Larger sample (urine)Larger sample (urine)
GC-MS or LC-MSGC-MS or LC-MS Instrument necessaryInstrument necessary Flexible open systemFlexible open system Reproducible resultsReproducible results Spectra Data BaseSpectra Data Base High separation efficiencyHigh separation efficiency High sensitivity-trace High sensitivity-trace
analysis (blood)analysis (blood) Low sample volume Low sample volume
(blood)(blood)
M. Balíková: Toxicological examination
19
Systematic TLC -1Systematic TLC -1Various systems developed in the worldVarious systems developed in the world
System by J. Večerková used overal System by J. Večerková used overal Czechoslovakia since 1970Czechoslovakia since 1970
SCREENINGSCREENING – 3 indicators to assess: – 3 indicators to assess:
1)1) Extractability – compound acidobasicityExtractability – compound acidobasicity
2)2) Compound mobility related to reference Compound mobility related to reference mixturemixture
3)3) Colour detection by set of reagentsColour detection by set of reagents
CONFIRMATIONCONFIRMATION >>> >>> Potential drug Potential drug candidates to be confirmed in other candidates to be confirmed in other chromatographic conditions with specific chromatographic conditions with specific reference standardsreference standards
M. Balíková: Toxicological examination
20
Systematic TLC -2Systematic TLC -2Practical application:Practical application:
Adsorbent : Kieselgel G - Adsorbent : Kieselgel G - MerckMerck
Mobile phase: ETOAC-ETOH-Mobile phase: ETOAC-ETOH-NH3NH3
11 – – REFERENCE STANDARDSREFERENCE STANDARDS
22- - URINE EXTRACT of BASESURINE EXTRACT of BASES
33- - URINE EXTRACT after URINE EXTRACT after HYDROLYSISHYDROLYSISPotentional intoxication with Potentional intoxication with
opiates and opiates and methamphetamine with methamphetamine with presence of nicotine – presence of nicotine – subsequent confirmation in subsequent confirmation in another system TLC or GC-MSanother system TLC or GC-MS
M. Balíková: Toxicological examination
21
FLEXIBLE METHOD FLEXIBLE METHOD APPLICATION in CONFIRMATIONAPPLICATION in CONFIRMATION
EXAMPLE: METHADONE EXAMPLE: METHADONE SUBSTITUTIONSUBSTITUTIONTARGETED OPIATE CONTROL in URINETARGETED OPIATE CONTROL in URINE
PROCEDURES APPLIED:PROCEDURES APPLIED:
M. Balíková: Toxicological examination
23
MAS SPECTRA and MAS SPECTRA and molecular structuremolecular structure
Direct reflection of molecular structureDirect reflection of molecular structure Destructive mass detectionDestructive mass detection Fragmentation reflects strength of Fragmentation reflects strength of
bondsbonds Fragmentation rules, logical Fragmentation rules, logical
mass losesmass loses Specificity of MSSpecificity of MS Structure modification Structure modification
to get specific spectrato get specific spectra
M. Balíková: Toxicological examination
24
Targeted opiates Targeted opiates confirmation by GC-MS confirmation by GC-MS
after positive IAafter positive IA Codeine Codeine
identificatioidentification byn by
1)1) RETENTIONRETENTION
2)2) MASS MASS SPECTRASPECTRA
HIGH REPRODUCIBILITY – MASS SPECTRA DATABASES
M. Balíková: Toxicological examination
25
Standard requirements for Standard requirements for correct compound correct compound
identification identification by GC-MSby GC-MS
Acceptable deviations in retention related to Acceptable deviations in retention related to standard standard (CODEINE RI=2375+/-1%)(CODEINE RI=2375+/-1%)
Acceptable deviations in individual fragment Acceptable deviations in individual fragment mass mass abundances abundances when compared when compared with standard with standard (CODEINE m/z 299(CODEINE m/z 299100 100
229229262616216246461241242323))
Logical molecular structure fragmentationLogical molecular structure fragmentation
Check for carry over in sample sequence Check for carry over in sample sequence
Included controls in sample sequenceIncluded controls in sample sequence
M. Balíková: Toxicological examination
26
GS-MS screening for GS-MS screening for unknownunknown drugdrug
Many psychoactive substances causing Many psychoactive substances causing intoxication need intoxication need not to be detected by not to be detected by commercial immunoassayscommercial immunoassays, e. g.:, e. g.:
Atropine, scopolamine,DMT…. Atropine, scopolamine,DMT….
Synthetic drugs, techno drugsSynthetic drugs, techno drugs
GHB, ………….GHB, ………….
Some of them can be detected by GC-MS Some of them can be detected by GC-MS screening system for unknownsscreening system for unknowns
Some of them to be detected require specific Some of them to be detected require specific sample preparation, specific chromatography sample preparation, specific chromatography (GHB) – suspicious cases, not routinely(GHB) – suspicious cases, not routinely
M. Balíková: Toxicological examination
27
Ayahuasca case - 1 case - 1Collective session of lucid thinking Collective session of lucid thinking supported by some oriental plant extract-supported by some oriental plant extract-more than 35 participants aged 20 – 50 yearsmore than 35 participants aged 20 – 50 years
40-60 min after ingestion participants 40-60 min after ingestion participants started to be agitated, agressive, with started to be agitated, agressive, with tachycardia, hyperthermia, dry skin, tachycardia, hyperthermia, dry skin, excessive salivation, some people fell into excessive salivation, some people fell into coma – coma – medicalmedical rescue service called rescue service called Urgent Urgent clinical need to clinical need to idetify the idetify the toxic agent – toxic agent –
for diferential diagnosis for diferential diagnosis
By laboratory GC-MS screening for uknown By laboratory GC-MS screening for uknown drugs identified in tea extract and in human drugs identified in tea extract and in human samples of blood, urine or gastric content : samples of blood, urine or gastric content : atropine,scopolamine, harmine, harmaline, atropine,scopolamine, harmine, harmaline, DMT DMT …..…..
M. Balíková: Toxicological examination
28
Ayahuasca case - 2 case - 2Subsequently partly determined: Subsequently partly determined:
Herbal infusion (free bases):Herbal infusion (free bases): atropine 27 mg/Latropine 27 mg/L harmine 179 mg/Lharmine 179 mg/L scopolamine 515 mg/Lscopolamine 515 mg/L
Estimated ingested dose (cup of Estimated ingested dose (cup of 150mL):150mL): atropine 4 mgatropine 4 mg harmine 27 mgharmine 27 mg scopolamine 78 mgscopolamine 78 mg
M. Balíková: Toxicological examination
29
Ayahuasca case - 3 case - 3Clinical impacts:Clinical impacts: All patients recoveredAll patients recovered Some were dismissed from hospitals after a Some were dismissed from hospitals after a few hrsfew hrs Some requirred intensice care for some daysSome requirred intensice care for some days
Forensic impacts:Forensic impacts:
The organizator taken into detention by police The organizator taken into detention by police and investigated – why? Defended himself with and investigated – why? Defended himself with no intention to harmno intention to harm anybody. Legal problem to anybody. Legal problem to prove the intention. Sent for psychiatric prove the intention. Sent for psychiatric examination. Found irresponsible for his examination. Found irresponsible for his behavior – dissmissed from detention without behavior – dissmissed from detention without any sanction. (However, ???)any sanction. (However, ???)
M. Balíková: Toxicological examination
30
IA missing response for IA missing response for structuraly related structuraly related amphetamines- FNamphetamines- FN
M. Balíková: Toxicological examination
31
DOB Case - important experience
4-bromo-2,5-dimethoxy-amphetamine4-bromo-2,5-dimethoxy-amphetamine
strong hallucinogen, effective dose strong hallucinogen, effective dose 1–3 mg1–3 mg
agonist of serotonin receptorsagonist of serotonin receptors
M. Balíková: Toxicological examination
32
DOB Case History - 1DOB Case History - 1
Two men ingested unknown powdered drug Two men ingested unknown powdered drug
Found in open space in coma vomitted with Found in open space in coma vomitted with severe severe crampscramps
Hospitalized in diffent departmentsHospitalized in diffent departments
Biological fluids sent for toxicology for Biological fluids sent for toxicology for unknownsunknowns
Laboratory applied general procedures Laboratory applied general procedures without without initial information what happenedinitial information what happened
One of men developed strong metabolic One of men developed strong metabolic acidosis acidosis pH 6.6 – laboratory check for pH 6.6 – laboratory check for methanol, diolsmethanol, diols
M. Balíková: Toxicological examination
33
DOB Case History - 2DOB Case History - 2
Immunochemical CEDIA for drug groups in Immunochemical CEDIA for drug groups in urine:urine:
THCOOTHCOOHH
COCAINCOCAINEE
AMPHETAMINEAMPHETAMINESS
M-28113 kg
positivepositive positivepositive negativenegative
M-2965 kg
positivepositive negativenegative negativenegative
M. Balíková: Toxicological examination
34
DOB Case HISTORY - 3DOB Case HISTORY - 3GC-MS GC-MS
screening screening for for
unknownsunknowns
Hit from Hit from MS PMW MS PMW LibraryLibrary
M. Balíková: Toxicological examination
35
DOB Case HISTORY - 4DOB Case HISTORY - 4
GC-MS GC-MS confirmation by confirmation by targeted targeted analysis for analysis for amines after amines after acetylationacetylation
Metabolism not Metabolism not known – known – research research biotransformatibiotransformation studyon study
M. Balíková: Toxicological examination
36
Hair analysis for drugsHair analysis for drugs
To get information about the life To get information about the life style of a subjectstyle of a subject
To document chronic drug abuse in To document chronic drug abuse in a specific time spana specific time span
To explain the pathological autopsy To explain the pathological autopsy findingsfindings
Trace analyses – GC-MS or LC-MS Trace analyses – GC-MS or LC-MS sensitive methods are prerequisitesensitive methods are prerequisite
More efficient incorporation of More efficient incorporation of bases than acidsbases than acids
M. Balíková: Toxicological examination
37
Hair analyses for Hair analyses for methamphetaminemethamphetamine
30 years old 30 years old man died man died shortly after shortly after drug drug application . application . Autopsy Autopsy revealed revealed arteriosclerosis arteriosclerosis and bleeding and bleeding into the into the cerebellum. cerebellum. Hair analyses Hair analyses documented documented chronic MA chronic MA abuse for abuse for approx. 8 approx. 8 months.months.
M. Balíková: Toxicological examination
38
Hair analyses for opiatesHair analyses for opiates
Deceased Deceased 24 years 24 years old old womanwoman
DocumentDocumented chronic ed chronic variable variable opiates opiates abuse for abuse for approx. 6 approx. 6 monthsmonths
M. Balíková: Toxicological examination
39
Hair analyses for drugs Hair analyses for drugs InterpretationInterpretation
Hair – stable sampleHair – stable sampleBiological variability in hair Biological variability in hair
growth growth and drug and drug incorporationincorporation
Individual attitude to a caseIndividual attitude to a caseStandards from sampling to Standards from sampling to
interpretation expressed by interpretation expressed by SOHT (Society for Hair Testing)SOHT (Society for Hair Testing)
M. Balíková: Toxicological examination
40
Basic literature:Basic literature: R. C. Baselt: Disposition of Toxic Drugs and Chemicals in Man. R. C. Baselt: Disposition of Toxic Drugs and Chemicals in Man.
Biomedical Publ., 6th ed., 2002 , Foster City, Ca. Biomedical Publ., 6th ed., 2002 , Foster City, Ca. B. Brinkman, B. Madea: Handbuch Gerichtliche Medizin. Springer B. Brinkman, B. Madea: Handbuch Gerichtliche Medizin. Springer
Vrlg. 2002, Berlin.Vrlg. 2002, Berlin. S. Moeschlin: Klinik und Therapie der Vergiftungen. George Thieme S. Moeschlin: Klinik und Therapie der Vergiftungen. George Thieme
Vrlg. 1986, Stuttgart.Vrlg. 1986, Stuttgart. H. Lüllmann, K. Mohr, M. Wehling: Pharmakologie und Toxikologie, H. Lüllmann, K. Mohr, M. Wehling: Pharmakologie und Toxikologie,
George Thieme Vrlg. 1999, Stuttgart.George Thieme Vrlg. 1999, Stuttgart. R. J. Flanagan, A. Taylor, I. D. Watson. R. Whelpton: Fundamental of R. J. Flanagan, A. Taylor, I. D. Watson. R. Whelpton: Fundamental of
Analytical Toxicology, Wiley, 2007, West Sussex.Analytical Toxicology, Wiley, 2007, West Sussex. S, B. Karch, ed.: Drug Abuse Handbook, CRC Press, 1998, Boca Raton.S, B. Karch, ed.: Drug Abuse Handbook, CRC Press, 1998, Boca Raton. O. H. Drummer, M. Odell: The Forensic Pharmacology of Drugs of O. H. Drummer, M. Odell: The Forensic Pharmacology of Drugs of
Abuse. Arnold Publ. 2001, London.Abuse. Arnold Publ. 2001, London. F. Pragst, M. Balíková: State of the art in hair analysis for detection of F. Pragst, M. Balíková: State of the art in hair analysis for detection of
drug and alcohol abuse. A review. Clinica Chimica Acta 370 (2006) 17-drug and alcohol abuse. A review. Clinica Chimica Acta 370 (2006) 17-49.49.